Cobb Carla D, Allen Shari N, Cusimano Joseph M, Ding Michelle, Eloma Amanda S, Ott Carol A, Tallian Kimberly B
Capital Consulting, Billings, Montana, USA.
PCOM Georgia School of Pharmacy, Suwanee, Georgia, USA.
Health Equity. 2023 Apr 19;7(1):223-234. doi: 10.1089/heq.2022.0189. eCollection 2023.
Social determinants of health (SDOH) affect outcomes of people living with psychiatric disorders, including substance use disorders. As experts in medication optimization, pharmacists play a vital role in identifying and addressing medication-related problems associated with SDOH. However, there is a paucity of literature on how pharmacists can be part of the solution.
The purpose of this article is to provide a narrative review and commentary on the intersection between SDOH, medication-related outcomes in people living with psychiatric disorders, and the role of pharmacists in addressing them.
The American Association of Psychiatric Pharmacists appointed an expert panel to research the issue, identify barriers, and develop a framework for including pharmacists in addressing medication therapy problems associated with SDOH in people with psychiatric disorders. The panel used Healthy People 2030 as the framework and sought input from public health officials to propose solutions for their commentary.
We identified potential connections between SDOH and their impact on medication use in people with psychiatric disorders. We provide examples of how comprehensive medication management can afford opportunities for pharmacists to mitigate medication-related problems associated with SDOH.
Public health officials should be aware of the vital role that pharmacists play in addressing medication therapy problems associated with SDOH to improve health outcomes and to incorporate them in health promotion programs.
健康的社会决定因素（SDOH）会影响患有精神疾病（包括物质使用障碍）的人群的治疗结果。作为药物优化方面的专家，药剂师在识别和解决与SDOH相关的药物问题方面发挥着至关重要的作用。然而，关于药剂师如何成为解决方案一部分的文献却很少。
本文旨在对SDOH、患有精神疾病人群的药物相关治疗结果以及药剂师在解决这些问题中的作用之间的交叉点进行叙述性综述和评论。
美国精神科药剂师协会任命了一个专家小组来研究这个问题，识别障碍，并制定一个框架，让药剂师参与解决患有精神疾病人群中与SDOH相关的药物治疗问题。该小组以《健康人民2030》为框架，并征求公共卫生官员的意见，以提出评论的解决方案。
我们确定了SDOH及其对患有精神疾病人群药物使用的影响之间的潜在联系。我们提供了一些例子，说明全面的药物管理如何为药剂师提供机会，以减轻与SDOH相关的药物问题。
公共卫生官员应意识到药剂师在解决与SDOH相关的药物治疗问题以改善健康结果并将他们纳入健康促进计划中所发挥的重要作用。
